Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRG
8376
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $538K | ﹤0.01% |
20,472
-60,638
| -75% | -$1.6M |
|
8377
PUT
AptarGroup
ATR
$8.38B
| $537K | ﹤0.01% |
5,200
-400
| -7% | -$43.6K |
|
8378
Harvard Bioscience
HBIO
$29.6M
| $537K | ﹤0.01% |
14,894
+12,884
| +641% | +$581K |
|
8379
iShares US Energy ETF
IYE
$1.84B
| $537K | ﹤0.01% |
14,100
+3,610
| +34% | +$153K |
|
8380
CALL
Ondas Inc
ONDS
$5.13B
| $537K | ﹤0.01% |
99,600
-100
| -0.1% | -$691 |
|
8381
PUT
Cullen/Frost Bankers
CFR
$10.4B
| $536K | ﹤0.01% |
4,600
+100
| +2% | +$12.8K |
|
8382
PUT
Healthpeak Properties
DOC
$14.2B
| $536K | ﹤0.01% |
+20,700
| New | +$627K |
|
8383
PUT
Greif
GEF
$4.97B
| $536K | ﹤0.01% |
8,600
-15,600
| -64% | -$953K |
|
8384
PUT
Hilltop Holdings
HTH
$2.25B
| $536K | ﹤0.01% |
+20,100
| New | +$573K |
|
8385
CALL
NeoGenomics
NEO
$2.08B
| $536K | ﹤0.01% |
65,800
-31,900
| -33% | -$305K |
|
|
NFBK
8386
DELISTED
Northfield Bancorp
NFBK
| $536K | ﹤0.01% |
+41,169
| New | +$540K |
|
8387
CALL
Tidewater
TDW
$4.68B
| $536K | ﹤0.01% |
25,400
+8,400
| +49% | +$193K |
|
8388
PUT
Essential Utilities
WTRG
$11.3B
| $536K | ﹤0.01% |
11,700
+3,900
| +50% | +$181K |
|
|
MMAT
8389
CALL
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $536K | ﹤0.01% |
5,207
+1,687
| +48% | +$252K |
|
|
SRC
8390
PUT
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $536K | ﹤0.01% |
14,200
+6,800
| +92% | +$286K |
|
8391
CALL
BGC Group
BGC
$5.31B
| $535K | ﹤0.01% |
158,800
-179,100
| -53% | -$624K |
|
8392
Tyra Biosciences
TYRA
$1.56B
| $535K | ﹤0.01% |
74,845
-3,464
| -4% | -$27.6K |
|
|
GRES
8393
DELISTED
IQ ARB Global Resources
GRES
| $535K | ﹤0.01% |
+17,338
| New | +$592K |
|
8394
Hingham Institution for Saving
HIFS
$663M
| $534K | ﹤0.01% |
+1,882
| New | +$591K |
|
8395
CALL
Invesco Energy Exploration & Production ETF
PXE
$84.9M
| $534K | ﹤0.01% |
+20,800
| New | +$622K |
|
8396
Veritone
VERI
$108M
| $534K | ﹤0.01% |
81,791
+51,262
| +168% | +$517K |
|
|
VRN
8397
CALL
DELISTED
Veren
VRN
| $534K | ﹤0.01% |
75,000
+34,500
| +85% | +$271K |
|
8398
CALL
Microvast
MVST
$310M
| $533K | ﹤0.01% |
240,300
-119,000
| -33% | -$511K |
|
|
NOTV
8399
DELISTED
Inotiv
NOTV
| $533K | ﹤0.01% |
55,512
-3,164
| -5% | -$53K |
|
8400
Artivion
AORT
$1.38B
| $532K | ﹤0.01% |
28,176
+2,679
| +11% | +$51.7K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.